The DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index.
Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology
Abstract
The development of α‐synuclein immunoreactive aggregates in selectively vulnerable neuronal types of the human central, peripheral, and enteric nervous systems is crucial for the pathogenesis of sporadic Parkinson's disease. The presence of these lesions persists into the end phase of the disease, a process that is not subject to remission. The initial induction of α‐synuclein misfolding and subsequent aggregation probably occurs in the olfactory bulb and/or the enteric nervous system. Each of these sites is exposed to potentially hostile environmental factors. Once formed, the aggregates appear to be capable of propagating trans‐synaptically from nerve cell to nerve cell in a virtually self‐promoting pathological process. A regional distribution pattern of aggregated α‐synuclein emerges that entails the involvement of only a few types of susceptible and axonally interconnected projection neurons within the human nervous system. One major route of disease progression may originate in the enteric nervous system and retrogradely reach the dorsal motor nucleus of the vagal nerve in the lower brainstem. From there, the disease process proceeds chiefly in a caudo‐rostral direction through visceromotor and somatomotor brainstem centres to the midbrain, forebrain, and cerebral cortex. Spinal cord centres may become involved by means of descending projections from involved lower brainstem nuclei as well as by sympathetic projections connecting the enteric nervous system with postganglionic peripheral ganglia and preganglionic nuclei of the spinal cord. The development of experimental cellular and animal models is helping to explain the mechanisms of how abnormal α‐synuclein can undergo aggregation and how transmission along axonal connectivities can occur, thereby encouraging the initiation of potential disease‐modifying therapeutic strategies for sporadic Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–273 of 273
Can Parkinson's disease pathology be propagated from one neuron to another?
Dunning, C. J. R., Reyes, J. F., Steiner, J. A., & Brundin, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.003 · Cited by 121
Morrison, L. A., Sidman, R. L., & Fields, B. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3852 · Cited by 115
How accurately can Parkinson's disease be diagnosed?
Wc, K. (1992) · PubMed · Cited by 114
The cellular pathology of Parkinson's disease
Takahashi, H., & Wakabayashi, K. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00403.x · Cited by 113
Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
Cox, D., Carver, J. A., & Ecroyd, H. W. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.024 · Cited by 112
The Temporal Lobe and Limbic System.
MacLean, P. D. (1998) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199811000-00015 · Cited by 109
Rinaman, L., Levitt, P. R., & Card, J. P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02731.2000 · Cited by 107
Jenner, P. G., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben‐Shlomo, Y., Bolam, J. P., Burn, D. J., Hindle, J. V., Brooks, D. J., et al. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130175 · Cited by 105
Alpha‐synuclein pathology in the olfactory pathways of dementia patients
Hubbard, P. S., Esiri, M. M., Reading, M. C., McShane, R. H., & Nagy, Z. (2007) · Journal of Anatomy · doi:10.1111/j.1469-7580.2007.00748.x · Cited by 105
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
MNH (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.677 · Cited by 103
Tanji, K., Mori, F., Mimura, J., Itoh, K., Kakita, A., Takahashi, H., & Wakabayashi, K. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0676-z · Cited by 102
Predominant affection of the blue cone pathway in Parkinson's disease
Haug, B. A., Kolle, R., Trenkwalder, C., Oertel, W. H., & Paulus, W. (1995) · Brain · doi:10.1093/brain/118.3.771 · Cited by 101
Goedert, M. (1997) · Nature · doi:10.1038/40767 · Cited by 100
Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease
Gai, W., Blessing, W. W., & Blumbergs, P. C. (1995) · Brain · doi:10.1093/brain/118.6.1447 · Cited by 99
Katsuse, O., Iseki, E., Marui, W., & Kosaka, K. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00037-6 · Cited by 98
The significance of tau and α-synuclein inclusions in neurodegenerative diseases
Goedert, M. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00200-8 · Cited by 95
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies
Leigh, P. N., Probst, A., Dale, G. E., Power, D., Brion, J., Dodson, A. R., & Anderton, B. H. (1989) · Acta Neuropathologica · doi:10.1007/bf00308959 · Cited by 90
The significance of defining preclinical or prodromal Parkinson's disease
Olanow, C. W., & Obeso, J. A. (2012) · Movement Disorders · doi:10.1002/mds.25019 · Cited by 90
Alpha‐synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients
Cersosimo, M. G., Perandones, C., Micheli, F. E., Raina, G. B., Beron, A. M., Nasswetter, G. G., Radrizzani, M., & Benarroch, E. E. (2010) · Movement Disorders · doi:10.1002/mds.23344 · Cited by 86
Noorian, A. R., Rha, J., Annerino, D. M., Bernhard, D., Taylor, G. M., & Greene, J. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.005 · Cited by 86
Chung, K. K. K., Dawson, V. L., & Dawson, T. M. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(01)00003-0 · Cited by 86
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Hansen, C., & Li, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.002 · Cited by 85
Parkinson's disease: chameleons and mimics
Ali, K., & Morris, H. R. (2014) · Practical Neurology · doi:10.1136/practneurol-2014-000849 · Cited by 84
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications
Chen, H., Burton, E. A., Ross, G. W., Huang, X., Savica, R., Abbott, R. D., Ascherio, A., Caviness, J. N., Gao, X., Gray, K. A., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306967 · Cited by 83
Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
Halliday, G. M., McCann, H., & Shepherd, C. E. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.47 · Cited by 83
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones
Bandopadhyay, R., & de Belleroche, J. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.11.004 · Cited by 83
Correlation Between Structural and Functional Retinal Changes in Parkinson Disease
Kaur, M., Saxena, R., Singh, D., Behari, M., Sharma, P., & Menon, V. (2015) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000240 · Cited by 81
Autonomic nervous system disturbances in Parkinson's disease.
Korczyn, A. D. (1990) · PubMed · Cited by 80
Jelliffe (1911) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-191105000-00015 · Cited by 80
Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies
Duda, J. E. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074677 · Cited by 80
Olfactory pathogenesis of idiopathic Parkinson disease revisited
Lerner, A., & Bagic, A. I. (2008) · Movement Disorders · doi:10.1002/mds.22066 · Cited by 80
Lesions outside the CNS in Parkinson's disease
Djaldetti, R., Lev, N., & Melamed, E. (2009) · Movement Disorders · doi:10.1002/mds.22172 · Cited by 78
Sumikura, H., Takao, M., Hatsuta, H., Ito, S., Nakano, Y., Uchino, A., Nogami, A., Saito, Y., Mochizuki, H., & Murayama, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0236-9 · Cited by 77
The intermediolateral nucleus and Clarke's column in Parkinson's disease
Wakabayashi, K., & Takahashi, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050705 · Cited by 76
View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication
Reichmann, H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.016 · Cited by 76
Lamberts, J. T., Hildebrandt, E. N., & Brundin, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.002 · Cited by 75
Atypical parkinsonism: an update
Stamelou, M., & Höglinger, G. U. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283632da6 · Cited by 73
van de Berg, W. D. J., Hepp, D. H., Dijkstra, A. A., Rozemüller, A. J. M., Berendse, H. W., & Foncke, E. M. J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70011-6 · Cited by 70
Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
Witt, S. N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8325-2 · Cited by 69
Incidental Lewy body disease restricted to the heart and stellate ganglia
Miki, Y., Mori, F., Wakabayashi, K., Kuroda, N., & Orimo, S. (2009) · Movement Disorders · doi:10.1002/mds.22775 · Cited by 67
Wakabayashi, K., Hansen, L. A., & Masliah, E. (1995) · Acta Neuropathologica · doi:10.1007/bf00307643 · Cited by 66
Parkinson’s Disease and Related Synucleinopathies are a New Class of Nervous System Amyloidoses
Trojanowski, J. Q., & Lee, V. M. ‐. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00065-7 · Cited by 66
Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
Pan-Montojo, F. J., & Reichmann, H. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-10 · Cited by 63
Orimo, S., Uchihara, T., Kanazawa, T., Itoh, Y., Wakabayashi, K., Kakita, A., & Takahashi, H. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01194.x · Cited by 62
Deguchi, K., Sasaki, I., Tsukaguchi, M., Kamoda, M., Touge, T., Takeuchi, H., & Kuriyama, S. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00079-5 · Cited by 61
Boeve, B. F., & Saper, C. B. (2006) · Neurology · doi:10.1212/01.wnl.0000209264.61035.bb · Cited by 61
Prasad, K., Beach, T. G., Hedreen, J. C., & Richfield, E. K. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00597.x · Cited by 60
Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals
Kanazawa, T., Adachi, E., Orimo, S., Nakamura, A., Mizusawa, H., & Uchihara, T. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00509.x · Cited by 57
Hyposialorrhea as an early manifestation of Parkinson disease
Cersósimo, M. G., Tumilasci, O. R., Raina, G. B., Benarroch, E. E., Cardoso, E. M., Micheli, F., & Pazo, J. H. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.04.004 · Cited by 54
Miki, Y., Tanji, K., Mori, F., Utsumi, J., Sasaki, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2015) · Brain Pathology · doi:10.1111/bpa.12297 · Cited by 54
Alpha-synuclein immunoreactivity patterns in the enteric nervous system
Aldecoa, I., Navarro‐Otano, J., Stefanova, N., Sprenger, F., Seppi, K., Poewe, W. H., Cuatrecasas, M., Valldeoriola, F., Gelpí, E., & Tolosa, E. S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.07.005 · Cited by 52
α‐synuclein pathology accumulates in sacral spinal visceral sensory pathways
VanderHorst, V., Samardzic, T., Saper, C. B., Anderson, M. P., Nag, S., Schneider, J. A., Bennett, D. A., & Buchman, A. S. (2015) · Annals of Neurology · doi:10.1002/ana.24430 · Cited by 51
Exploring brain circuitry with neurotropic viruses: New horizons in neuroanatomy
Card, J. P. (1998) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199812)253:6<176::aid-ar6>3.0.co;2-w · Cited by 49
Dugger, B. N., & Dickson, D. W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0739-1 · Cited by 49
Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism
Navarro‐Otano, J., Gelpí, E., Mestres, C. A., Quintana, E., Rauek, S. G., Ribalta, T., Santiago, V., & TOLOSA, E. S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.005 · Cited by 48
Mu, L., Chen, J., Sobótka, S., Nyirenda, T. L., Benson, B. E., Gupta, F., Sanders, I., Adler, C. H., Caviness, J. N., Shill, H. A., et al. (2015) · Dysphagia · doi:10.1007/s00455-015-9612-7 · Cited by 47
Gl, C., James, T., & Nk, M. (1979) · PubMed · Cited by 46
Defining the Native State of α-Synuclein
Selkoe, D., Dettmer, U., Luth, E., Kim, N., Newman, A., & Bartels, T. (2014) · Neurodegenerative Diseases · doi:10.1159/000355516 · Cited by 45
Любашина, О. А., Jolkkonen, E., & Pitkänen, A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01392-6 · Cited by 43
Parkinson's disease: Before the motor symptoms and beyond
Korczyn, A. D., & Gurevich, T. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.032 · Cited by 39
Lewy body‐related α‐synucleinopathy in the spinal cord of cases with incidental Lewy body disease
Tamura, T., Yoshida, M., Hashizume, Y., & Sobue, G. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01211.x · Cited by 36
Parkinson's disease as a member of Prion-like disorders
Herva, M. E., & Spillantini, M. G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.016 · Cited by 35
Baker, H. A., & Genter, M. B. (2003) · CRC Press eBooks · doi:10.1201/9780203911457.ch26 · Cited by 34
Miwa, H., Kubo, T., Suzuki, A., & Kondo, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.003 · Cited by 32
Targeting the Chameleon: a Focused Look at α-Synuclein and Its Roles in Neurodegeneration
Silva, B. A., Breydo, L., & Uversky, V. N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8334-1 · Cited by 31
Braak, H., Tredici, K. D., Gai, W., & Braak, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00101-0 · Cited by 27
Self-citationα‐Synuclein pathology in the cranial and spinal nerves in Lewy body disease
Nakamura, K., Mori, F., Tanji, K., Miki, Y., Toyoshima, Y., Kakita, A., Takahashi, H., Yamada, M., & Wakabayashi, K. (2015) · Neuropathology · doi:10.1111/neup.12269 · Cited by 27
Potential role of viruses in neurodegeneration
Kristensson, K. (1992) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159960 · Cited by 24
Marreiros, R., Müller‐Schiffmann, A., Bader, V., Selvarajah, S., Dey, D., Lingappa, V. R., & Korth, C. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.003 · Cited by 17
Watelet, J., Strolin‐Benedetti, M., & Whomsley, R. (2009) · PubMed · Cited by 15
Does a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology?
Sacino, A. N., & Giasson, B. I. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt151 · Cited by 7
Goedert, M., & Cheng, Y. (2015) · Nature · doi:10.1038/nature15630 · Cited by 7
Meeting Summary--Cell Biology of Parkinson's Disease and Related Neurodegenerative Disorders
Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.32.pe23 · Cited by 4
Cited by
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Mao, X., Ou, M. T., Karuppagounder, S. S., Kam, T.-I., Yin, X., Xiong, Y., Ge, P., Umanah, G. E., Brahmachari, S., Shin, J.-H., et al. (2016) · Science · doi:10.1126/science.aah3374 · Cited by 690
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0238-6 · Cited by 450
Exploring Braak’s hypothesis of Parkinson’s disease
Rietdijk, C. D., Perez-Pardo, P., Garssen, J., van Wezel, R. J. A., & Kraneveld, A. D. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00037 · Cited by 395
An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration
Moreno-García, A., Kun, A., Calero, O., Medina, M., & Calero, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00464 · Cited by 372
Metadata
- Authors
- Del Tredici, K., & Braak, H.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2016-02
- Volume
- 42
- Issue
- 1
- Pages
- 33-50
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2195120335
- Cited by
- 398
- References
- 273
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.